Intradermal Injection Market Snapshot (2022 to 2032)
The global intradermal injection market is expected to surpass an impressive valuation of US$ 3,878 Million in 2022 and is projected to exhibit a compound annual growth rate (CAGR) of 10.8% from 2022 to 2032.
In recent years, technological advancements have led to the development of surgical approaches with the aim to minimize waste and achieve better results. The reusable intradermal devices result in low waste generation, having a net positive effect on the productivity of an economy.
Along with this, the results of several meta-analyses prove that intradermal delivery of drugs reduces the intensity of adverse events. The factors mentioned above indicate the favorable condition for the rapid growth of this segment in the future.
Report Attribute
Details
Expected Market Value (2022)
US$ 3,878 Million
Anticipated Forecast Value (2032)
US$ 10,814.47 Million
Projected Growth Rate (2022 to 2032)
10.8% CAGR
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
2017 to 2021 Intradermal Injection Demand Analysis vs. Forecast 2022 to 2032
Over the past two decades, there has been an increase in the demand for intradermal injections. This is due to the rising incidence of diseases with a simultaneous increase in the use of intradermal vaccination and aesthetic procedures.
Furthermore, the growing burden of chronic diseases has led to a rise in the overall use of syringes, particularly disposable syringes, intradermal jet injectors, microinjections, and ballistic intradermal injection treatment and diagnostic purposes. Theglobal demand for Intradermal Injections is projected to increase at a CAGR of 10.8% during the forecast period between 2022 and 2032, reaching a total of US$ 10,814.47 Million in 2032, according to a report from Future Market Insights (FMI). From 2017 to 2021, sales witnessed significant growth, registering a CAGR of 8%.
Which are Some Prominent Drivers of the Intradermal Injection Market?
Growing Prevalence of Chronic Diseases, Increase in Aesthetic Surgical Procedures to Catalyse Intradermal Injection Uptake
The rising prevalence rate of tuberculosis is expected to promote the growth rate of the intradermal injection market. As per the data of WHO, tuberculosis is the 13th leading cause of death, and about 10 million cases of TB have been recorded every year, which resulted in a sudden rise in the diagnostic rate of TB during the last decade. This is one of the major factors that act as one of the leading reasons for increasing the intradermal injection market size of tuberculin syringes.
In addition to this, the number of aesthetic procedures is increasing rapidly in North America and Europe. The intradermal vaccination reduces the potential dose of antigens, improves the immune response, and decreases the anxiety associated with the vaccination. Moreover, aesthetic procedures are the leading segment of local aesthetic procedures, increasing the demand for intradermal injections.
Almost all vaccines require cold chain distribution and storage, which further limits resources or refrigerator space in a healthcare setting. Globally, approximately 17.4 million people are prone to rabies through animal bites annually. It occurs in more than 150 territories and countries, rabies is a viral disease that can cause encephalitis when transmitted to humans. Intradermal injections immensely help in lowering the cost of cell-derived vaccines for pre-exposure to rabies. The cost-savings with intradermal injections for rabies create immense opportunities for the intradermal injections market.
Find your sweet spots for generating winning opportunities in this market.
What are the Challenges Projected to be Faced by the Market?
Unfavorable Government Provisions to Hinder Market Growth
Despite the advantages shown through various clinical studies, there are various barriers that hinder the usage of intradermal injections. The major world economies across Europe, the United States, and other developed regions rely on single-dose formats and have government funding or private insurance for vaccination. Emerging markets are anticipated to favor multi-dose formats and are limited by availability and cost of supply.
Region-wise Insights
What Makes the United States the Largest Market for Intradermal Injection?
Increased Prevalence of Diseases to drive the adoption of intradermal Injection
According to the American Cancer Society’s 2022 report, over 1.9 million new cancers are expected to be recorded in the United States in 2022. Also, as per the same source, the risk of having cancer rises dramatically as one gets older, and in the United States, 80% of cancer patients are 55 or older, with 57% being 65 or older. These figures tell that the growing geriatric population is expected to have a significant positive impact on the growth of the market.
Not just this but according to the International Diabetes Federation’s report of December 2021, about 32.2 million people were living with diabetes in the United States in 2021, and this number is estimated to increase to 36.3 million by 2045. This expansion in the diabetes patient pool is expected to boost growth in intradermal injection in the United States.
Why is the United Kingdom Considered a Lucrative Region for the Intradermal Injection Market?
The Increasing Prevalence of Diabetes is Spurring Demand for Intradermal Injection
As per the International Diabetes Federation (IDF) Diabetes Atlas 2021, the age-adjusted comparative prevalence of diabetes in the United Kingdom for 2021, 2030, and 2045 were estimated as 6.3%, 7.0%, and 7.5% respectively. Therefore, the gradual rise in the prevalence of diabetes is expected to increase the market demand.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need and save 40%!
Category-wise Insights
Which Method Type Leads the Market for Intradermal Injection?
Normal Sized Needles to Lead the Method Type of Intradermal Injection
Based on the method, the intradermal injection market is segmented into normal-sized needles, short needles, and without needles. As per our research, normal-sized needles dominate the market, while the short-needle segment is estimated to register considerable growth.
By Application, Which Segment is Projected to Lead the Market?
Tuberculin Skin Test Segment is Estimated to Hold the Largest Share
Based on application, the market is segmented into tuberculin skin tests, allergy tests, local aesthetics, and others. The tuberculin skin test segment is estimated to hold the largest share of the market in 2022, accounting for 58% of total demand, while the local aesthetic segment is expected to register the highest CAGR during the forecast period.
Market Competition
Key players in the Intradermal Injection market are Becton Dickinson, Cardinal Health, West Pharmaceuticals Services, Terumo Corporation, Nanopass, Pharmajet, Idevax, Enusung, Crossject, and Hindustan Syringes and Medical Devices.
In May 2022, Stevanato Group S.p.A. signed an exclusive agreement with leading medical device developer and manufacturer Owen Mumford Ltd. for its Aidaptus auto-injector. Adeptus is a 2-step, single-use auto-injector with a versatile design that accommodates both 1 mL and 2.25 mL prefilled glass syringes in the same base device.
In May 2020, Takeda Pharmaceutical Company Limited received approval from the European Commission for the subcutaneous (SC) formulation of Entyvio (vedolizumab), a gut-selective biologic for use as maintenance therapy in adults with moderately to severely active ulcerative colitis (UC) or Crohn’s disease (CD). Entyvio SC is available in both a pre-filled syringe and a pre-filled pen.
Terumo Corporation is a pioneer in hypodermic needle innovation. The company offers a comprehensive platform of precision-engineered needle and needle stick prevention technologies ready for the most challenging applications and high-throughput processing environments. The company helps design and deliver safer, less painful injections to ensure the therapeutic success of the drug product. Some of its products include the Nanopass® 34G Needle for Pen Injectors, the Neolus Needles, SurGuard® Safety Hypodermic Needles, the SurGuard® 3 Safety Hypodermic Needles, and the Terumo 3-Part Syringe.
In May 2021, Crossject announced further strengthening of its partnership with long-term collaborator Cenexi to ramp up industrial-scale manufacturing of the ZENEO® needle-free auto-injection. With this announcement, Cenexi strengthened its positioning on innovation and sterile manufacturing expertise thanks to its human-scale agility, and its recognized skills in pharmaceutical development.
Report Scope
Report Attribute
Details
Market Value in 2022
US$ 3,878 Million
Market Value in 2032
US$ 10,814.47 Million
Growth Rate
CAGR of 10.8% from 2022 to 2032
Base Year for Estimation
2021
Historical Data
2017 to 2021
Forecast Period
2022 to 2032
Quantitative Units
Revenue in USD Billion and CAGR from 2022 to 2032
Report Coverage
Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis
Segments Covered
Method
Application
End User
Region
Regions Covered
North America
Latin America
Europe
South Asia
East Asia
Oceania
Middle East & Africa
Key Countries Profiled
The USA
Canada
Brazil
Mexico
Germany
The United Kingdom
France
Spain
Italy
India
Malaysia
Singapore
Thailand
China
Japan
South Korea
Australia
New Zealand
GCC
South Africa
Israel
Key Companies Profiled
Becton Dickinson
Cardinal Health
West Pharmaceuticals Services
Terumo Corporation
Nanopass
Pharmajet
Idevax
Enusung
Crossject
Hindustan Syringes and Medical Devices
Customization
Available Upon Request
Key Segments Profiled in the Intradermal Injection Market Industry Survey
Intradermal Injection Market by Method:
Normal Sized Needles
Short Needle
Intradermal Microinjection
Microneedle Arrays
Tattoo Devices
Without Needle
Intradermal Liquid Jet Devices and
Ballistic Intradermal Injectors
Intradermal Injection Market by Application:
Tuberculin Skin Test
Allergy Test
Local Aesthetics
Others
Intradermal Injection Market by End User:
Hospitals
Diagnostic Laboratories
Academics and Research Institutes
Others
Intradermal Injection Market by Region:
North America
Europe
South Asia
East Asia
Oceania
Latin America
Middle East and Africa (MEA)
Frequently Asked Questions
What is the anticipated growth of the market Intradermal Injection until 2032?
FMI projects the global Intradermal Injection market to expand at a 10.8% value CAGR by 2032.
What is the estimated market value of the Intradermal Injection market expected in 2022?
The global Intradermal Injection market is estimated at a market value of US$ 2.5 Billion.
What is the estimated market value of the Intradermal Injection market expected in 2032?
The global Intradermal Injection market is expected to garner a market value of US$ 10814.47 Million.
Which region is forecast to be the most lucrative for Intradermal Injection market growth?
FMI has projected North America to be one of the key regions for the Intradermal Injection market.
Which are some prominent Intradermal Injection manufacturers?
Becton Dickinson, Cardinal Health, West Pharmaceuticals services, Terumo Corporation, Nanopass, Pharmajet, Idevax, Enusung, Crossject, and Hindustan Syringes and Medical Devices.
Table of Content
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Investment Feasibility Matrix
3.5. PESTLE and Porter’s Analysis
3.6. Regulatory Landscape
3.6.1. By Key Regions
3.6.2. By Key Countries
3.7. Regional Parent Market Outlook
4. Global Market Analysis 2017 to 2021 and Forecast, 2022 to 2032
4.1. Historical Market Size Value (US$ million) Analysis, 2017 to 2021
4.2. Current and Future Market Size Value (US$ million) Projections, 2022 to 2032
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Method
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ million) Analysis By Method, 2017 to 2021
5.3. Current and Future Market Size Value (US$ million) Analysis and Forecast By Method, 2022 to 2032
5.3.1. Normal Sized Needles
5.3.2. Short Needle
5.3.2.1. Intradermal Microinjection
5.3.2.2. Microneedle Arrays
5.3.2.3. Tattoo Devices
5.3.3. Without Needle
5.3.3.1. Intradermal Liquid Jet Devices
5.3.3.2. Ballistic Intradermal Injectors
5.4. Y-o-Y Growth Trend Analysis By Method, 2017 to 2021
5.5. Absolute $ Opportunity Analysis By Method, 2022 to 2032
6. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Application
6.1. Introduction / Key Findings
6.2. Historical Market Size Value (US$ million) Analysis By Application, 2017 to 2021
6.3. Current and Future Market Size Value (US$ million) Analysis and Forecast By Application, 2022 to 2032
6.3.1. Tuberculin Skin Test
6.3.2. Allergy Test
6.3.3. Local Aesthetics
6.3.4. Others
6.4. Y-o-Y Growth Trend Analysis By Application, 2017 to 2021
6.5. Absolute $ Opportunity Analysis By Application, 2022 to 2032
7. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By End User
7.1. Introduction / Key Findings
7.2. Historical Market Size Value (US$ million) Analysis By End User, 2017 to 2021
7.3. Current and Future Market Size Value (US$ million) Analysis and Forecast By End User, 2022 to 2032
7.3.1. Hospitals
7.3.2. Diagnostic Laboratories
7.3.3. Academics And Research Institutes
7.3.4. Others
7.4. Y-o-Y Growth Trend Analysis By End User, 2017 to 2021
7.5. Absolute $ Opportunity Analysis By End User, 2022 to 2032
8. Global Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Region
8.1. Introduction
8.2. Historical Market Size Value (US$ million) Analysis By Region, 2017 to 2021
8.3. Current Market Size Value (US$ million) Analysis and Forecast By Region, 2022 to 2032
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. South Asia
8.3.5. East Asia
8.3.6. Oceania
8.3.7. Middle East and Africa (MEA)
8.4. Market Attractiveness Analysis By Region
9. North America Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
9.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2017 to 2021
9.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2022 to 2032
9.2.1. By Country
9.2.1.1. The USA
9.2.1.2. Canada
9.2.2. By Method
9.2.3. By Application
9.2.4. By End User
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Method
9.3.3. By Application
9.3.4. By End User
9.4. Key Takeaways
10. Latin America Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
10.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2017 to 2021
10.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2022 to 2032
10.2.1. By Country
10.2.1.1. Brazil
10.2.1.2. Mexico
10.2.1.3. Rest of Latin America
10.2.2. By Method
10.2.3. By Application
10.2.4. By End User
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Method
10.3.3. By Application
10.3.4. By End User
10.4. Key Takeaways
11. Europe Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
11.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2017 to 2021
11.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2022 to 2032
11.2.1. By Country
11.2.1.1. Germany
11.2.1.2. United Kingdom
11.2.1.3. France
11.2.1.4. Spain
11.2.1.5. Italy
11.2.1.6. Rest of Europe
11.2.2. By Method
11.2.3. By Application
11.2.4. By End User
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Method
11.3.3. By Application
11.3.4. By End User
11.4. Key Takeaways
12. South Asia Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
12.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2017 to 2021
12.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2022 to 2032
12.2.1. By Country
12.2.1.1. India
12.2.1.2. Malaysia
12.2.1.3. Singapore
12.2.1.4. Thailand
12.2.1.5. Rest of South Asia
12.2.2. By Method
12.2.3. By Application
12.2.4. By End User
12.3. Market Attractiveness Analysis
12.3.1. By Country
12.3.2. By Method
12.3.3. By Application
12.3.4. By End User
12.4. Key Takeaways
13. East Asia Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
13.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2017 to 2021
13.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2022 to 2032
13.2.1. By Country
13.2.1.1. China
13.2.1.2. Japan
13.2.1.3. South Korea
13.2.2. By Method
13.2.3. By Application
13.2.4. By End User
13.3. Market Attractiveness Analysis
13.3.1. By Country
13.3.2. By Method
13.3.3. By Application
13.3.4. By End User
13.4. Key Takeaways
14. Oceania Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
14.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2017 to 2021
14.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2022 to 2032
14.2.1. By Country
14.2.1.1. Australia
14.2.1.2. New Zealand
14.2.2. By Method
14.2.3. By Application
14.2.4. By End User
14.3. Market Attractiveness Analysis
14.3.1. By Country
14.3.2. By Method
14.3.3. By Application
14.3.4. By End User
14.4. Key Takeaways
15. MEA Market Analysis 2017 to 2021 and Forecast 2022 to 2032, By Country
15.1. Historical Market Size Value (US$ million) Trend Analysis By Market Taxonomy, 2017 to 2021
15.2. Market Size Value (US$ million) Forecast By Market Taxonomy, 2022 to 2032
15.2.1. By Country
15.2.1.1. GCC Countries
15.2.1.2. South Africa
15.2.1.3. Israel
15.2.1.4. Rest of MEA
15.2.2. By Method
15.2.3. By Application
15.2.4. By End User
15.3. Market Attractiveness Analysis
15.3.1. By Country
15.3.2. By Method
15.3.3. By Application
15.3.4. By End User
15.4. Key Takeaways
16. Key Countries Market Analysis
16.1. The USA
16.1.1. Pricing Analysis
16.1.2. Market Share Analysis, 2021
16.1.2.1. By Method
16.1.2.2. By Application
16.1.2.3. By End User
16.2. Canada
16.2.1. Pricing Analysis
16.2.2. Market Share Analysis, 2021
16.2.2.1. By Method
16.2.2.2. By Application
16.2.2.3. By End User
16.3. Brazil
16.3.1. Pricing Analysis
16.3.2. Market Share Analysis, 2021
16.3.2.1. By Method
16.3.2.2. By Application
16.3.2.3. By End User
16.4. Mexico
16.4.1. Pricing Analysis
16.4.2. Market Share Analysis, 2021
16.4.2.1. By Method
16.4.2.2. By Application
16.4.2.3. By End User
16.5. Germany
16.5.1. Pricing Analysis
16.5.2. Market Share Analysis, 2021
16.5.2.1. By Method
16.5.2.2. By Application
16.5.2.3. By End User
16.6. The United Kingdom
16.6.1. Pricing Analysis
16.6.2. Market Share Analysis, 2021
16.6.2.1. By Method
16.6.2.2. By Application
16.6.2.3. By End User
16.7. France
16.7.1. Pricing Analysis
16.7.2. Market Share Analysis, 2021
16.7.2.1. By Method
16.7.2.2. By Application
16.7.2.3. By End User
16.8. Spain
16.8.1. Pricing Analysis
16.8.2. Market Share Analysis, 2021
16.8.2.1. By Method
16.8.2.2. By Application
16.8.2.3. By End User
16.9. Italy
16.9.1. Pricing Analysis
16.9.2. Market Share Analysis, 2021
16.9.2.1. By Method
16.9.2.2. By Application
16.9.2.3. By End User
16.10. India
16.10.1. Pricing Analysis
16.10.2. Market Share Analysis, 2021
16.10.2.1. By Method
16.10.2.2. By Application
16.10.2.3. By End User
16.11. Malaysia
16.11.1. Pricing Analysis
16.11.2. Market Share Analysis, 2021
16.11.2.1. By Method
16.11.2.2. By Application
16.11.2.3. By End User
16.12. Singapore
16.12.1. Pricing Analysis
16.12.2. Market Share Analysis, 2021
16.12.2.1. By Method
16.12.2.2. By Application
16.12.2.3. By End User
16.13. Thailand
16.13.1. Pricing Analysis
16.13.2. Market Share Analysis, 2021
16.13.2.1. By Method
16.13.2.2. By Application
16.13.2.3. By End User
16.14. China
16.14.1. Pricing Analysis
16.14.2. Market Share Analysis, 2021
16.14.2.1. By Method
16.14.2.2. By Application
16.14.2.3. By End User
16.15. Japan
16.15.1. Pricing Analysis
16.15.2. Market Share Analysis, 2021
16.15.2.1. By Method
16.15.2.2. By Application
16.15.2.3. By End User
16.16. South Korea
16.16.1. Pricing Analysis
16.16.2. Market Share Analysis, 2021
16.16.2.1. By Method
16.16.2.2. By Application
16.16.2.3. By End User
16.17. Australia
16.17.1. Pricing Analysis
16.17.2. Market Share Analysis, 2021
16.17.2.1. By Method
16.17.2.2. By Application
16.17.2.3. By End User
16.18. New Zealand
16.18.1. Pricing Analysis
16.18.2. Market Share Analysis, 2021
16.18.2.1. By Method
16.18.2.2. By Application
16.18.2.3. By End User
16.19. GCC Countries
16.19.1. Pricing Analysis
16.19.2. Market Share Analysis, 2021
16.19.2.1. By Method
16.19.2.2. By Application
16.19.2.3. By End User
16.20. South Africa
16.20.1. Pricing Analysis
16.20.2. Market Share Analysis, 2021
16.20.2.1. By Method
16.20.2.2. By Application
16.20.2.3. By End User
16.21. Israel
16.21.1. Pricing Analysis
16.21.2. Market Share Analysis, 2021
16.21.2.1. By Method
16.21.2.2. By Application
16.21.2.3. By End User
17. Market Structure Analysis
17.1. Competition Dashboard
17.2. Competition Benchmarking
17.3. Market Share Analysis of Top Players
17.3.1. By Regional
17.3.2. By Method
17.3.3. By Application
17.3.4. By End User
18. Competition Analysis
18.1. Competition Deep Dive
18.1.1. Becton Dickinson
18.1.1.1. Overview
18.1.1.2. Product Portfolio
18.1.1.3. Profitability by Market Segments
18.1.1.4. Sales Footprint
18.1.1.5. Strategy Overview
18.1.1.5.1. Marketing Strategy
18.1.2. Cardinal Health
18.1.2.1. Overview
18.1.2.2. Product Portfolio
18.1.2.3. Profitability by Market Segments
18.1.2.4. Sales Footprint
18.1.2.5. Strategy Overview
18.1.2.5.1. Marketing Strategy
18.1.3. West Pharmaceuticals services
18.1.3.1. Overview
18.1.3.2. Product Portfolio
18.1.3.3. Profitability by Market Segments
18.1.3.4. Sales Footprint
18.1.3.5. Strategy Overview
18.1.3.5.1. Marketing Strategy
18.1.4. Terumo Corporation
18.1.4.1. Overview
18.1.4.2. Product Portfolio
18.1.4.3. Profitability by Market Segments
18.1.4.4. Sales Footprint
18.1.4.5. Strategy Overview
18.1.4.5.1. Marketing Strategy
18.1.5. Nanopass
18.1.5.1. Overview
18.1.5.2. Product Portfolio
18.1.5.3. Profitability by Market Segments
18.1.5.4. Sales Footprint
18.1.5.5. Strategy Overview
18.1.5.5.1. Marketing Strategy
18.1.6. Pharmajet
18.1.6.1. Overview
18.1.6.2. Product Portfolio
18.1.6.3. Profitability by Market Segments
18.1.6.4. Sales Footprint
18.1.6.5. Strategy Overview
18.1.6.5.1. Marketing Strategy
18.1.7. Idevax
18.1.7.1. Overview
18.1.7.2. Product Portfolio
18.1.7.3. Profitability by Market Segments
18.1.7.4. Sales Footprint
18.1.7.5. Strategy Overview
18.1.7.5.1. Marketing Strategy
18.1.8. Enusung
18.1.8.1. Overview
18.1.8.2. Product Portfolio
18.1.8.3. Profitability by Market Segments
18.1.8.4. Sales Footprint
18.1.8.5. Strategy Overview
18.1.8.5.1. Marketing Strategy
18.1.9. Crossject
18.1.9.1. Overview
18.1.9.2. Product Portfolio
18.1.9.3. Profitability by Market Segments
18.1.9.4. Sales Footprint
18.1.9.5. Strategy Overview
18.1.9.5.1. Marketing Strategy
18.1.10. Hindustan Syringes
18.1.10.1. Overview
18.1.10.2. Product Portfolio
18.1.10.3. Profitability by Market Segments
18.1.10.4. Sales Footprint
18.1.10.5. Strategy Overview
18.1.10.5.1. Marketing Strategy
19. Assumptions & Acronyms Used20. Research Methodology
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
List of Tables
Table 1: Global Market Value (US$ million) Forecast by Region, 2017 to 2032
Table 2: Global Market Value (US$ million) Forecast by Method, 2017 to 2032
Table 3: Global Market Value (US$ million) Forecast by Application, 2017 to 2032
Table 4: Global Market Value (US$ million) Forecast by End User, 2017 to 2032
Table 5: North America Market Value (US$ million) Forecast by Country, 2017 to 2032
Table 6: North America Market Value (US$ million) Forecast by Method, 2017 to 2032
Table 7: North America Market Value (US$ million) Forecast by Application, 2017 to 2032
Table 8: North America Market Value (US$ million) Forecast by End User, 2017 to 2032
Table 9: Latin America Market Value (US$ million) Forecast by Country, 2017 to 2032
Table 10: Latin America Market Value (US$ million) Forecast by Method, 2017 to 2032
Table 11: Latin America Market Value (US$ million) Forecast by Application, 2017 to 2032
Table 12: Latin America Market Value (US$ million) Forecast by End User, 2017 to 2032
Table 13: Europe Market Value (US$ million) Forecast by Country, 2017 to 2032
Table 14: Europe Market Value (US$ million) Forecast by Method, 2017 to 2032
Table 15: Europe Market Value (US$ million) Forecast by Application, 2017 to 2032
Table 16: Europe Market Value (US$ million) Forecast by End User, 2017 to 2032
Table 17: South Asia Market Value (US$ million) Forecast by Country, 2017 to 2032
Table 18: South Asia Market Value (US$ million) Forecast by Method, 2017 to 2032
Table 19: South Asia Market Value (US$ million) Forecast by Application, 2017 to 2032
Table 20: South Asia Market Value (US$ million) Forecast by End User, 2017 to 2032
Table 21: East Asia Market Value (US$ million) Forecast by Country, 2017 to 2032
Table 22: East Asia Market Value (US$ million) Forecast by Method, 2017 to 2032
Table 23: East Asia Market Value (US$ million) Forecast by Application, 2017 to 2032
Table 24: East Asia Market Value (US$ million) Forecast by End User, 2017 to 2032
Table 25: Oceania Market Value (US$ million) Forecast by Country, 2017 to 2032
Table 26: Oceania Market Value (US$ million) Forecast by Method, 2017 to 2032
Table 27: Oceania Market Value (US$ million) Forecast by Application, 2017 to 2032
Table 28: Oceania Market Value (US$ million) Forecast by End User, 2017 to 2032
Table 29: MEA Market Value (US$ million) Forecast by Country, 2017 to 2032
Table 30: MEA Market Value (US$ million) Forecast by Method, 2017 to 2032
Table 31: MEA Market Value (US$ million) Forecast by Application, 2017 to 2032
Table 32: MEA Market Value (US$ million) Forecast by End User, 2017 to 2032
Find your sweet spots for generating winning opportunities in this market.
List of Charts
Figure 1: Global Market Value (US$ million) by Method, 2022 to 2032
Figure 2: Global Market Value (US$ million) by Application, 2022 to 2032
Figure 3: Global Market Value (US$ million) by End User, 2022 to 2032
Figure 4: Global Market Value (US$ million) by Region, 2022 to 2032
Figure 5: Global Market Value (US$ million) Analysis by Region, 2017 to 2032
Figure 6: Global Market Value Share (%) and BPS Analysis by Region, 2022 to 2032
Figure 7: Global Market Y-o-Y Growth (%) Projections by Region, 2022 to 2032
Figure 8: Global Market Value (US$ million) Analysis by Method, 2017 to 2032
Figure 9: Global Market Value Share (%) and BPS Analysis by Method, 2022 to 2032
Figure 10: Global Market Y-o-Y Growth (%) Projections by Method, 2022 to 2032
Figure 11: Global Market Value (US$ million) Analysis by Application, 2017 to 2032
Figure 12: Global Market Value Share (%) and BPS Analysis by Application, 2022 to 2032
Figure 13: Global Market Y-o-Y Growth (%) Projections by Application, 2022 to 2032
Figure 14: Global Market Value (US$ million) Analysis by End User, 2017 to 2032
Figure 15: Global Market Value Share (%) and BPS Analysis by End User, 2022 to 2032
Figure 16: Global Market Y-o-Y Growth (%) Projections by End User, 2022 to 2032
Figure 17: Global Market Attractiveness by Method, 2022 to 2032
Figure 18: Global Market Attractiveness by Application, 2022 to 2032
Figure 19: Global Market Attractiveness by End User, 2022 to 2032
Figure 20: Global Market Attractiveness by Region, 2022 to 2032
Figure 21: North America Market Value (US$ million) by Method, 2022 to 2032
Figure 22: North America Market Value (US$ million) by Application, 2022 to 2032
Figure 23: North America Market Value (US$ million) by End User, 2022 to 2032
Figure 24: North America Market Value (US$ million) by Country, 2022 to 2032
Figure 25: North America Market Value (US$ million) Analysis by Country, 2017 to 2032
Figure 26: North America Market Value Share (%) and BPS Analysis by Country, 2022 to 2032
Figure 27: North America Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032
Figure 28: North America Market Value (US$ million) Analysis by Method, 2017 to 2032
Figure 29: North America Market Value Share (%) and BPS Analysis by Method, 2022 to 2032
Figure 30: North America Market Y-o-Y Growth (%) Projections by Method, 2022 to 2032
Figure 31: North America Market Value (US$ million) Analysis by Application, 2017 to 2032
Figure 32: North America Market Value Share (%) and BPS Analysis by Application, 2022 to 2032
Figure 33: North America Market Y-o-Y Growth (%) Projections by Application, 2022 to 2032
Figure 34: North America Market Value (US$ million) Analysis by End User, 2017 to 2032
Figure 35: North America Market Value Share (%) and BPS Analysis by End User, 2022 to 2032
Figure 36: North America Market Y-o-Y Growth (%) Projections by End User, 2022 to 2032
Figure 37: North America Market Attractiveness by Method, 2022 to 2032
Figure 38: North America Market Attractiveness by Application, 2022 to 2032
Figure 39: North America Market Attractiveness by End User, 2022 to 2032
Figure 40: North America Market Attractiveness by Country, 2022 to 2032
Figure 41: Latin America Market Value (US$ million) by Method, 2022 to 2032
Figure 42: Latin America Market Value (US$ million) by Application, 2022 to 2032
Figure 43: Latin America Market Value (US$ million) by End User, 2022 to 2032
Figure 44: Latin America Market Value (US$ million) by Country, 2022 to 2032
Figure 45: Latin America Market Value (US$ million) Analysis by Country, 2017 to 2032
Figure 46: Latin America Market Value Share (%) and BPS Analysis by Country, 2022 to 2032
Figure 47: Latin America Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032
Figure 48: Latin America Market Value (US$ million) Analysis by Method, 2017 to 2032
Figure 49: Latin America Market Value Share (%) and BPS Analysis by Method, 2022 to 2032
Figure 50: Latin America Market Y-o-Y Growth (%) Projections by Method, 2022 to 2032
Figure 51: Latin America Market Value (US$ million) Analysis by Application, 2017 to 2032
Figure 52: Latin America Market Value Share (%) and BPS Analysis by Application, 2022 to 2032
Figure 53: Latin America Market Y-o-Y Growth (%) Projections by Application, 2022 to 2032
Figure 54: Latin America Market Value (US$ million) Analysis by End User, 2017 to 2032
Figure 55: Latin America Market Value Share (%) and BPS Analysis by End User, 2022 to 2032
Figure 56: Latin America Market Y-o-Y Growth (%) Projections by End User, 2022 to 2032
Figure 57: Latin America Market Attractiveness by Method, 2022 to 2032
Figure 58: Latin America Market Attractiveness by Application, 2022 to 2032
Figure 59: Latin America Market Attractiveness by End User, 2022 to 2032
Figure 60: Latin America Market Attractiveness by Country, 2022 to 2032
Figure 61: Europe Market Value (US$ million) by Method, 2022 to 2032
Figure 62: Europe Market Value (US$ million) by Application, 2022 to 2032
Figure 63: Europe Market Value (US$ million) by End User, 2022 to 2032
Figure 64: Europe Market Value (US$ million) by Country, 2022 to 2032
Figure 65: Europe Market Value (US$ million) Analysis by Country, 2017 to 2032
Figure 66: Europe Market Value Share (%) and BPS Analysis by Country, 2022 to 2032
Figure 67: Europe Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032
Figure 68: Europe Market Value (US$ million) Analysis by Method, 2017 to 2032
Figure 69: Europe Market Value Share (%) and BPS Analysis by Method, 2022 to 2032
Figure 70: Europe Market Y-o-Y Growth (%) Projections by Method, 2022 to 2032
Figure 71: Europe Market Value (US$ million) Analysis by Application, 2017 to 2032
Figure 72: Europe Market Value Share (%) and BPS Analysis by Application, 2022 to 2032
Figure 73: Europe Market Y-o-Y Growth (%) Projections by Application, 2022 to 2032
Figure 74: Europe Market Value (US$ million) Analysis by End User, 2017 to 2032
Figure 75: Europe Market Value Share (%) and BPS Analysis by End User, 2022 to 2032
Figure 76: Europe Market Y-o-Y Growth (%) Projections by End User, 2022 to 2032
Figure 77: Europe Market Attractiveness by Method, 2022 to 2032
Figure 78: Europe Market Attractiveness by Application, 2022 to 2032
Figure 79: Europe Market Attractiveness by End User, 2022 to 2032
Figure 80: Europe Market Attractiveness by Country, 2022 to 2032
Figure 81: South Asia Market Value (US$ million) by Method, 2022 to 2032
Figure 82: South Asia Market Value (US$ million) by Application, 2022 to 2032
Figure 83: South Asia Market Value (US$ million) by End User, 2022 to 2032
Figure 84: South Asia Market Value (US$ million) by Country, 2022 to 2032
Figure 85: South Asia Market Value (US$ million) Analysis by Country, 2017 to 2032
Figure 86: South Asia Market Value Share (%) and BPS Analysis by Country, 2022 to 2032
Figure 87: South Asia Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032
Figure 88: South Asia Market Value (US$ million) Analysis by Method, 2017 to 2032
Figure 89: South Asia Market Value Share (%) and BPS Analysis by Method, 2022 to 2032
Figure 90: South Asia Market Y-o-Y Growth (%) Projections by Method, 2022 to 2032
Figure 91: South Asia Market Value (US$ million) Analysis by Application, 2017 to 2032
Figure 92: South Asia Market Value Share (%) and BPS Analysis by Application, 2022 to 2032
Figure 93: South Asia Market Y-o-Y Growth (%) Projections by Application, 2022 to 2032
Figure 94: South Asia Market Value (US$ million) Analysis by End User, 2017 to 2032
Figure 95: South Asia Market Value Share (%) and BPS Analysis by End User, 2022 to 2032
Figure 96: South Asia Market Y-o-Y Growth (%) Projections by End User, 2022 to 2032
Figure 97: South Asia Market Attractiveness by Method, 2022 to 2032
Figure 98: South Asia Market Attractiveness by Application, 2022 to 2032
Figure 99: South Asia Market Attractiveness by End User, 2022 to 2032
Figure 100: South Asia Market Attractiveness by Country, 2022 to 2032
Figure 101: East Asia Market Value (US$ million) by Method, 2022 to 2032
Figure 102: East Asia Market Value (US$ million) by Application, 2022 to 2032
Figure 103: East Asia Market Value (US$ million) by End User, 2022 to 2032
Figure 104: East Asia Market Value (US$ million) by Country, 2022 to 2032
Figure 105: East Asia Market Value (US$ million) Analysis by Country, 2017 to 2032
Figure 106: East Asia Market Value Share (%) and BPS Analysis by Country, 2022 to 2032
Figure 107: East Asia Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032
Figure 108: East Asia Market Value (US$ million) Analysis by Method, 2017 to 2032
Figure 109: East Asia Market Value Share (%) and BPS Analysis by Method, 2022 to 2032
Figure 110: East Asia Market Y-o-Y Growth (%) Projections by Method, 2022 to 2032
Figure 111: East Asia Market Value (US$ million) Analysis by Application, 2017 to 2032
Figure 112: East Asia Market Value Share (%) and BPS Analysis by Application, 2022 to 2032
Figure 113: East Asia Market Y-o-Y Growth (%) Projections by Application, 2022 to 2032
Figure 114: East Asia Market Value (US$ million) Analysis by End User, 2017 to 2032
Figure 115: East Asia Market Value Share (%) and BPS Analysis by End User, 2022 to 2032
Figure 116: East Asia Market Y-o-Y Growth (%) Projections by End User, 2022 to 2032
Figure 117: East Asia Market Attractiveness by Method, 2022 to 2032
Figure 118: East Asia Market Attractiveness by Application, 2022 to 2032
Figure 119: East Asia Market Attractiveness by End User, 2022 to 2032
Figure 120: East Asia Market Attractiveness by Country, 2022 to 2032
Figure 121: Oceania Market Value (US$ million) by Method, 2022 to 2032
Figure 122: Oceania Market Value (US$ million) by Application, 2022 to 2032
Figure 123: Oceania Market Value (US$ million) by End User, 2022 to 2032
Figure 124: Oceania Market Value (US$ million) by Country, 2022 to 2032
Figure 125: Oceania Market Value (US$ million) Analysis by Country, 2017 to 2032
Figure 126: Oceania Market Value Share (%) and BPS Analysis by Country, 2022 to 2032
Figure 127: Oceania Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032
Figure 128: Oceania Market Value (US$ million) Analysis by Method, 2017 to 2032
Figure 129: Oceania Market Value Share (%) and BPS Analysis by Method, 2022 to 2032
Figure 130: Oceania Market Y-o-Y Growth (%) Projections by Method, 2022 to 2032
Figure 131: Oceania Market Value (US$ million) Analysis by Application, 2017 to 2032
Figure 132: Oceania Market Value Share (%) and BPS Analysis by Application, 2022 to 2032
Figure 133: Oceania Market Y-o-Y Growth (%) Projections by Application, 2022 to 2032
Figure 134: Oceania Market Value (US$ million) Analysis by End User, 2017 to 2032
Figure 135: Oceania Market Value Share (%) and BPS Analysis by End User, 2022 to 2032
Figure 136: Oceania Market Y-o-Y Growth (%) Projections by End User, 2022 to 2032
Figure 137: Oceania Market Attractiveness by Method, 2022 to 2032
Figure 138: Oceania Market Attractiveness by Application, 2022 to 2032
Figure 139: Oceania Market Attractiveness by End User, 2022 to 2032
Figure 140: Oceania Market Attractiveness by Country, 2022 to 2032
Figure 141: MEA Market Value (US$ million) by Method, 2022 to 2032
Figure 142: MEA Market Value (US$ million) by Application, 2022 to 2032
Figure 143: MEA Market Value (US$ million) by End User, 2022 to 2032
Figure 144: MEA Market Value (US$ million) by Country, 2022 to 2032
Figure 145: MEA Market Value (US$ million) Analysis by Country, 2017 to 2032
Figure 146: MEA Market Value Share (%) and BPS Analysis by Country, 2022 to 2032
Figure 147: MEA Market Y-o-Y Growth (%) Projections by Country, 2022 to 2032
Figure 148: MEA Market Value (US$ million) Analysis by Method, 2017 to 2032
Figure 149: MEA Market Value Share (%) and BPS Analysis by Method, 2022 to 2032
Figure 150: MEA Market Y-o-Y Growth (%) Projections by Method, 2022 to 2032
Figure 151: MEA Market Value (US$ million) Analysis by Application, 2017 to 2032
Figure 152: MEA Market Value Share (%) and BPS Analysis by Application, 2022 to 2032
Figure 153: MEA Market Y-o-Y Growth (%) Projections by Application, 2022 to 2032
Figure 154: MEA Market Value (US$ million) Analysis by End User, 2017 to 2032
Figure 155: MEA Market Value Share (%) and BPS Analysis by End User, 2022 to 2032
Figure 156: MEA Market Y-o-Y Growth (%) Projections by End User, 2022 to 2032
Figure 157: MEA Market Attractiveness by Method, 2022 to 2032
Figure 158: MEA Market Attractiveness by Application, 2022 to 2032
Figure 159: MEA Market Attractiveness by End User, 2022 to 2032
Figure 160: MEA Market Attractiveness by Country, 2022 to 2032
